The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
27 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,025,370 in first-year total cost, median $37,249.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-0 (A1)]27
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)1
- CORNELL UNIVERSITY1
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Manipulation of three-dimensional chromatin structure to regulate oncogenes in breast and ovarian cancer.1F99CA222541-01 | MORGAN, STEFANIE L | STANFORD UNIVERSITY, CA | $45,544 | ZCA1 |
| 2017 | Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy1F99CA222711-01 | SCHARPING, NICOLE E | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $45,544 | ZCA1 |
| 2017 | The role of DNMT3A in gene regulation and stem cell expansion1F99CA222736-01 | HUANG, YUNG-HSIN | BAYLOR COLLEGE OF MEDICINE, TX | $45,544 | ZCA1 |
| 2017 | Metabolic rewiring regulates cancer growth and tumor-associated immune responses1F99CA222741-01 | ZHAO, STEVEN | UNIVERSITY OF PENNSYLVANIA, PA | $45,544 | ZCA1 |
| 2017 | Leveraging epigenetic and epitranscriptomic aberrations in cancer to identify molecular targets for designing therapy1F99CA223044-01 | SUNDARAVEL, SRIRAM | UNIVERSITY OF CHICAGO, IL | $45,544 | ZCA1 |
| 2017 | Role of the tumor microenvironment in promoting drug resistance in castration resistant prostate cancer1F99CA223063-01 | ZHANG, ZEDA | SLOAN-KETTERING INST CAN RESEARCH, NY | $45,544 | ZCA1 |
| 2017 | Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levels1F99CA223074-01 | MA, PUI-YAN VICTOR | EMORY UNIVERSITY, GA | $45,544 | ZCA1 |
| 2017 | Metabolic and Genetic Heterogeneity in Cancer1F99CA222986-01 | LIBERTI, MARIA V | CORNELL UNIVERSITY, NY | $42,024 | ZCA1 |
| 2017 | Overcoming Tumor Resistance to Chemotherapy with Multiscale Diffuse and Nonlinear Imaging1F99CA223014-01 | KARROBI, KAVON | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $41,455 | ZCA1 |
| 2017 | Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation1F99CA222722-01 | BABATUNDE, OLUWOLE ADEYEMI | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $40,727 | ZCA1 |
| 2017 | Class III PI3K as an Autophagy Reactivation Switch in Malignant Transformation1F99CA223029-01 | YOUNG, LINDSEY N | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $40,723 | ZCA1 |
| 2017 | Particulate Delivery of STING Agonist as Anti-cancer Immuotherapeutics and Cancer Microbiome1F99CA223019-01 | CHENG, NING | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $38,879 | ZCA1 |
| 2017 | Investigating the epigenetics of enhancer function in Cancer1F99CA222988-01 | RICKELS, RYAN ADAM | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $38,192 | ZCA1 |
| 2017 | GABPB1L-mediated activation of the mutant TERT promoter as a therapeutic target in glioblastoma1F99CA222987-01 | MANCINI, ANDREW G | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $37,249 | ZCA1 |
| 2017 | Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies1F99CA222728-01 | ANDERSON, GRACE R | DUKE UNIVERSITY, NC | $36,630 | ZCA1 |
| 2017 | Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors1F99CA222742-01 | WILLIAMS, ANNALYNN | UNIVERSITY OF ROCHESTER, NY | $35,290 | ZCA1 |
| 2017 | Deciphering the role of Six2 in regulating cancer stem cell properties and promoting late-stage metastasis in breast cancer.1F99CA223023-01 | OLIPHANT, MICHAEL UJ | UNIVERSITY OF COLORADO DENVER, CO | $34,404 | ZCA1 |
| 2017 | Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell Level1F99CA222750-01 | FAN, JEAN | HARVARD UNIVERSITY, MA | $33,667 | ZCA1 |
| 2017 | A Biopsychosocial Approach to Behavioral Oncology in Young Adults1F99CA222727-01 | DARABOS, KATIE | HUNTER COLLEGE, NY | $33,279 | ZCA1 |
| 2017 | Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer1F99CA223015-01 | MOLLAOGLU, GURKAN | UNIVERSITY OF UTAH, UT | $33,187 | ZCA1 |
| 2017 | Novel Relationships between BER Glycosylases and Mutagenic DNA Adducts1F99CA222725-01 | DEVITO, STEPHEN R | GEORGETOWN UNIVERSITY, DC | $32,977 | ZCA1 |
| 2017 | A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets1F99CA223018-01 | MICKOLAJCZYK, KEITH JOSEPH | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $32,868 | ZCA1 |
| 2017 | Investigating cancer metabolism and its potential for therapeutic intervention1F99CA223016-01 | MONTAL, EMILY DINA | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $32,806 | ZCA1 |
| 2017 | Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy1F99CA223064-01 | ROYCHOUDHURY, SHRABASTI | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $31,171 | ZCA1 |
| 2017 | Targeting inflammation and immune response in HNSCC therapy1F99CA223062-01 | ESPINOSA-COTTON, MADELYN | UNIVERSITY OF IOWA, IA | $31,037 | ZCA1 |
| 2017 | The regulation of mutant p53 protein accumulation and GOF activity in tumors1F99CA222734-01 | ZHAO, YUHAN | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $30,343 | ZCA1 |
| 2017 | Defining the barriers to immune surveillance in solid tumors1F99CA223043-01 | HEGDE, SAMARTH | WASHINGTON UNIVERSITY, MO | $29,654 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.